Vera Therapeutics

IPO

Truth in science. Transformation in medicine.

Public · Brisbane, United States · $114.0M raised

Headquarters
Brisbane
Employees
201–500
Business Model
B2B
Website
veratx.com
Total Funding
$114.0M
Last Round
$80.0M Series CJan 2021
Rounds
2
Type
Public

About

Vera Therapeutics pursues truth in science to transform medicine in autoimmune diseases, starting with the kidney. Its research targets the immune pathways that drive kidney disease, aiming for a future where patients with autoimmune-driven kidney diseases are free from dialysis or transplant. Founded by a physician who saw the limits of existing treatments, the late clinical-stage company develops candidates such as atacicept that address the source of immunological disease rather than only symptoms.

Summary

Vera Therapeutics is a Biotech company based in Brisbane, United States. It has raised $114.0M in total across 2 rounds, most recently a $80.0M Series C round in Jan 2021.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOMay 2021

Sign up to see all 3 rounds

Series B through IPO — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vera Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/vera-therapeutics"><img src="https://indexed.vc/api/badge/company/vera-therapeutics" alt="Vera Therapeutics on Indexed.vc" width="260" height="76" /></a>